Anika Therapeutics Inc share price logo

Anika Therapeutics Inc Share Price

NASDAQ: ANIK

Small Cap

$14.26

+0.41

(+2.96%)

as on

Anika Therapeutics Inc Stock Performance

as on March 24, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $13.98
    $14.35
    downward going graph

    1.96%

    Downside

    0.63%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $7.87
    $15.79
    downward going graph

    44.81%

    Downside

    10.73%

    Upside

    downward going graph

Anika Therapeutics Inc share price movements today

Previous Close
$13.85
Open
$13.98
Volume
248.2K
Day's Low - High
$13.98 - $14.35
52 Week Low - High
$7.87 - $15.79

Anika Therapeutics Inc Historical Returns

1 Month Return
+ 26.83 %
3 Month Return
+ 47.5 %
1 Year Return
-10.18 %
3 Year Return
-50.62 %
5 Year Return
-59.26 %

Anika Therapeutics Inc Stock Fundamentals & Key Indicators

Check Anika Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$199.7M

EPS (TTM)

0.25

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.51%

PE Ratio (TTM)

-5.11

Industry PE ratio

-4.068794117647059

PEG Ratio

5.536

EBITDA

-5.5M

Revenue (TTM)

112.8M

Profit Margin

-9.64%

Return On Equity TTM

-6.71%

Anika Therapeutics Inc Stock Valuation

Track how Anika Therapeutics Inc P/E has moved over time to understand its valuation trends.

Anika Therapeutics Inc in the last 5 years

  • Overview

  • Trends

Lowest (-75.86x)

March 31, 2021

Today (-5.11x)

March 23, 2026

Industry (-4.07x)

March 23, 2026

Highest (138.02x)

December 31, 2021

LowHigh

Today’s Price to Earnings Ratio: -5.11x

Anika Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Anika Therapeutics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Anika Therapeutics Inc image
Anika Therapeutics Inc
BUY$199.7M-59.26%-5.11-9.64%
United Therapeutics Corporation image
United Therapeutics Corporation
BUY$23.0BNA18.8141.94%
Viatris Inc. image
Viatris Inc.
HOLD$15.2B-6.85%-21.95-24.58%
Haleon Plc Spon Ads image
Haleon Plc Spon Ads
BUY$44.8BNA20.5515.11%
Zoetis Inc. image
Zoetis Inc.
BUY$51.0B-25.87%19.2528.24%

Stock Returns calculator for Anika Therapeutics Inc Stock including INR - Dollar returns

The Anika Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Anika Therapeutics Inc investment value today

Current value as on today

₹1,02,397

Returns

₹2,397

(+2.4%)

Returns from Anika Therapeutics Inc Stock

₹7,523 (-7.52%)

Dollar Returns*

₹9,919 (+9.92%)

Analyst Recommendation on Anika Therapeutics Inc Stock

Based on 9 analysts

BUY

77.78%

Buy

22.22%

Hold

0.00%

Sell

Based on 9 analysts, 77.78% of analysts recommend a 'BUY' rating for Anika Therapeutics Inc. Average target price of $17.5

Anika Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Anika Therapeutics Inc.

What analysts predicted

18.51%UPSIDE

Target Price

$17.5

Current Price

$14.26

Analyzed by

9 Analysts

Target

$17.50

Anika Therapeutics Inc target price $17.5, a slight upside of 18.51% compared to current price of $14.26. According to 9 analysts rating.

Anika Therapeutics Inc Stock’s Investor Sentiment and Interest

Search interest for Anika Therapeutics Inc Stock has increased by 100% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:100% versus previous 30 day period

Anika Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
41
42
40
30
38
-1
26
28
27
30
Gross Profit
24
26
24
20
1
22
14
14
15
19
Operating Income
-7
-63
-5
-1
-28
27
-4
-4
-3
0
EBITDA
-4
1
-1
0
-25
26
-2
-2
0
2
Interest Expense
-
1
0
-
-
-
0
0
1
0
Depreciation
3
3
2
2
2
1
1
1
1
1
Income Before Tax
-7
-63
-4
-1
-27
28
-3
-3
-2
0
Income Tax Expense
0
0
0
1
2
2
0
0
0
-1
Net Income
-6
-63
-4
0
-29
-21
-4
-3
-2
0
Net Profit Margin
-15.86%
-146.61%
-11.14%
-0.29%
-77.20%
1694.96%
-18.62%
-14.07%
-8.37%
0.95%

Anika Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
103
113
105
114
130
147
156
120
119
112
Gross Profit
79
86
74
85
69
82
93
82
75
63
Operating Income
50
45
21
34
-28
2
-19
0
-5
-11
EBITDA
54
50
27
40
-1
-4
-4
15
3
-1
Interest Expense
0
0
1
7
0
0
0
2
2
1
Depreciation
-
4
5
5
13
14
14
14
8
5
Income Before Tax
50
46
23
36
-28
2
-18
3
-2
-9
Income Tax Expense
18
14
4
8
-4
-1
-3
6
6
0
Net Income
32
31
18
27
-23
4
-14
-82
-56
-10
Net Profit Margin
31.48%
28.05%
17.74%
23.73%
-18.38%
2.80%
-9.51%
-68.44%
-47.02%
-9.64%

Anika Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-63
-1
0
-29
-21
-4
-3
-2
0
Operating Cash Flow
3
0
-1
5
1
0
0
6
4
Investing Cash Flow
-1
-1
-3
-1
-1
1
0
-1
0
Financing Cash Flow
0
-2
-1
-3
-5
-5
0
0
-5
Change in Cash
2
0
-5
0
-5
-3
0
4
0

Anika Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
31
18
27
-23
4
-14
-82
-56
-10
Operating Cash Flow
40
34
37
13
8
4
-1
5
11
Investing Cash Flow
-12
-50
39
-71
-3
-7
-5
-8
0
Financing Cash Flow
0
-28
-8
-3
-6
-4
-6
-12
-10
Change in Cash
28
-44
68
-61
-1
-8
-13
-15
0

Global Institutional Holdings in Anika Therapeutics Inc

Funds
Holdings
Caligan Partners LP
10.71%
Acadian Asset Management LLC
4.72%
Renaissance Technologies Corp
3.85%
Geode Capital Management, LLC
2.43%
Stonepine Capital Management Llc
1.32%
See all

Insights on Anika Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 27.81M → 30.61M (in $), with an average increase of 9.1% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, ANIK stock has moved up by 26.8%

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 6 quarters, -29.91M → 292.0K (in $), with an average increase of 275.3% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, United Therapeutics Corporation has given 142.7% return, outperforming this stock by 193.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, United Therapeutics Corporation has given 67.5% return, outperforming this stock by 77.7%

About Anika Therapeutics Inc

who we are we are anika therapeutics, a global medical technology company at the forefront of pain management, tissue regeneration and wound healing. we are committed to delivering innovative medical solutions that help patients feel better faster, look and feel younger and remain active. with over 7 million procedures performed over the past twenty years utilizing our proprietary technology, anika is helping individuals all over the world return to life naturally. our guiding principles we are innovators and creators. we value strong discipline and exceptional focus from our personnel, and we employ lean principles and agile processes in managing our business. this foundation of guiding values, combined with our entrepreneurial spirit, gives anika the ability and fortitude to generate innovative ideas and to grow our portfolio of successful products. what we do anika offers a broad spectrum of therapeutic treatments ranging from pain management and tissue regeneration to wound care an
OrganisationAnika Therapeutics Inc
Headquarters32 Wiggins Avenue, Bedford, MA, United States, 01730
IndustryHealth Technology
CEOMr. Stephen D. Griffin
E-voting on sharesClick here to vote

Key Management of Anika Therapeutics Inc

Name

Title

Ms. Lisa Funiciello

Vice President of Human Resources

Dr. Cheryl Renee Blanchard Ph.D.

Executive Chair

Mr. David Colleran J.D.

Executive VP, General Counsel & Corporate Secretary

Mr. Ian W. McLeod

VP, Chief Accounting Officer & Treasurer

Mr. Matthew Hall

Director of Corporate Development & Investor Relations

Ms. Mira Leiwant

Senior Vice President of Regulatory, Quality & Clinical Affairs

Mr. Stephen D. Griffin

President, Principal Financial Officer, CEO & Director

Mr. Mark Namaroff

Vice President of Investor Relations, ESG & Corporate Communications

Mr. James Chase

Senior Vice President of International Sales & Marketing

Mr. Ben Joseph

Vice President of Commercial & Corporate Development

FAQs

What is Anika Therapeutics Inc share price today?

Anika Therapeutics Inc share price today is $14.26 as on at the close of the market. Anika Therapeutics Inc share today touched a day high of $14.35 and a low of $13.98.

What is the 52 week high and 52 week low for Anika Therapeutics Inc share?

Anika Therapeutics Inc share touched a 52 week high of $15.79 on and a 52 week low of $7.87 on . Anika Therapeutics Inc stock price today i.e. is closed at $14.26,which is 9.69% down from its 52 week high and 81.19% up from its 52 week low.

What is Anika Therapeutics Inc's market capitalisation today?

Anika Therapeutics Inc market capitalisation is $0.00T as on .

How to invest in Anika Therapeutics Inc Stock (ANIK) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Anika Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Anika Therapeutics Inc Shares that will get you 0.1052 shares as per Anika Therapeutics Inc share price of $14.26 per share as on March 24, 2026 at 1:29 am IST.

What is the minimum amount required to buy Anika Therapeutics Inc Stock (ANIK) from India?

Indian investors can start investing in Anika Therapeutics Inc (ANIK) shares with as little as ₹94.058 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹940.58 in Anika Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Anika Therapeutics Inc share’s latest price of $14.26 as on March 24, 2026 at 1:29 am IST, you will get 0.7013 shares of Anika Therapeutics Inc. Learn more about fractional shares .

What are the returns that Anika Therapeutics Inc has given to Indian investors in the last 5 years?

Anika Therapeutics Inc stock has given -59.26% share price returns and 29.13% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?